Terms: = Sarcomas AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
582 results:
1. Undifferentiated Embryonal Sarcoma of the Liver with Epithelioid Features: A Case Report of an Exceptional Histological Heterogeneity among Rare Diseases.
Kersik A; Bracchetti G; Bonomi A; Bovo G; Serena Cuttin M; Germini A; Gjoni E; Granieri S; Cotsoglou C
Ann Ital Chir; 2024; 95(2):119-125. PubMed ID: 38684493
[TBL] [Abstract] [Full Text] [Related]
2. Biomechanical and clinical outcomes of 3D-printed versus modular hemipelvic prostheses for limb-salvage reconstruction following periacetabular tumor resection: a mid-term retrospective cohort study.
Hu X; Wen Y; Lu M; Luo Y; Zhou Y; Yang X; Tu C; Min L
J Orthop Surg Res; 2024 Apr; 19(1):258. PubMed ID: 38654343
[TBL] [Abstract] [Full Text] [Related]
3. Functional and oncological outcomes of patients with proximal humerus osteosarcoma managed by limb salvage.
Sadek WMS; Elshamly IKF; Salem MSM; AbouSenna WG; Ebeid E; Ebeid WA
J Orthop Traumatol; 2024 Apr; 25(1):18. PubMed ID: 38637478
[TBL] [Abstract] [Full Text] [Related]
4. Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors.
Hoch CC; Knoedler L; Knoedler S; Bashiri Dezfouli A; Schmidl B; Trill A; Douglas JE; Adappa ND; Stögbauer F; Wollenberg B
Curr Oncol Rep; 2024 Mar; 26(3):272-291. PubMed ID: 38376625
[TBL] [Abstract] [Full Text] [Related]
5. Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence.
Benhima N; Belbaraka R; Langouo Fontsa MD
Curr Opin Oncol; 2024 Mar; 36(2):69-73. PubMed ID: 38193381
[TBL] [Abstract] [Full Text] [Related]
6. Kaposiform Hemangioendothelioma with Bone Destruction: A 16-Year Follow-Up Cohort Study of the Clinical Characteristics and Prognosis.
Qiu T; Zhang Z; Liu J; Zhou J; Gong X; Lan Y; Zhang X; Chen S; Ji Y
J Pediatr Surg; 2024 Apr; 59(4):599-604. PubMed ID: 38158257
[TBL] [Abstract] [Full Text] [Related]
7. Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives.
Huynh THN; Kuruvilla DR; Nester MD; Zervoudakis G; Letson GD; Joyce DM; Binitie OT; Lazarides AL
Curr Oncol Rep; 2023 Dec; 25(12):1457-1465. PubMed ID: 37999825
[TBL] [Abstract] [Full Text] [Related]
8. Liposarcoma of spermatic cord mimicking an inguinal hernia A case report and review of the literature.
Tinozzi FP; Calì B; Bertolami M; Rebba A; Morone G; Albertario S; Abbiati F; Osman N; Ruggiero R
Ann Ital Chir; 2023 Oct; 12():. PubMed ID: 37990578
[TBL] [Abstract] [Full Text] [Related]
9. Epilepsy in gliomas: recent insights into risk factors and molecular pathways.
Rudà R; Bruno F; Pellerino A
Curr Opin Neurol; 2023 Dec; 36(6):557-563. PubMed ID: 37865836
[TBL] [Abstract] [Full Text] [Related]
10. What Are the Complication Rates and Factors Associated With Total Femur Replacement After Tumor Resection? Findings From the Japanese Musculoskeletal Oncology Group.
Mori T; Kobayashi E; Sato Y; Takenaka S; Endo M; Nakamura T; Morii T; Yoshida Y; Ueda T; Kawano H; Kawai A
Clin Orthop Relat Res; 2024 Apr; 482(4):702-712. PubMed ID: 37796200
[TBL] [Abstract] [Full Text] [Related]
11. Does A Single Osteotomy Technique for Frozen Autograft (Pedicled Freezing) in Patients With Malignant Bone Tumors of the Long Bones Achieve Union and Local Tumor Control?
El Masry AM; Azmy SI; Rahman Mustafa MA; Abuelhadid MA
Clin Orthop Relat Res; 2024 Feb; 482(2):340-349. PubMed ID: 37589950
[TBL] [Abstract] [Full Text] [Related]
12. Operative treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data.
Bozzo A; Yeung CM; Van De Sande M; Ghert M; Healey JH;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):65-72. PubMed ID: 37466582
[TBL] [Abstract] [Full Text] [Related]
13. Incidence of and Risk Factors for Thromboembolism After Endoprosthetic Reconstruction in Musculoskeletal Oncology Patients.
Sabharwal S; LiBrizzi CL; Forsberg JA; Morris CD; Levin AS;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):29-33. PubMed ID: 37466577
[TBL] [Abstract] [Full Text] [Related]
14. Naldemedine-induced opioid withdrawal with restlessness as the predominant symptom in a palliative care setting.
Sato R; Ishida M; Uchida N; Sakimoto T; Yamaguchi T; Ooya Y; Takahashi T; Onishi H
Palliat Support Care; 2023 Oct; 21(5):957-959. PubMed ID: 37350233
[TBL] [Abstract] [Full Text] [Related]
15. Advances in Osteosarcoma.
Panez-Toro I; Muñoz-García J; Vargas-Franco JW; Renodon-Cornière A; Heymann MF; Lézot F; Heymann D
Curr Osteoporos Rep; 2023 Aug; 21(4):330-343. PubMed ID: 37329384
[TBL] [Abstract] [Full Text] [Related]
16. Ultrasound stiffness and perfusion markers correlate with tumor volume responses to immunotherapy.
Voutouri C; Mpekris F; Panagi M; Krolak C; Michael C; Martin JD; Averkiou MA; Stylianopoulos T
Acta Biomater; 2023 Sep; 167():121-134. PubMed ID: 37321529
[TBL] [Abstract] [Full Text] [Related]
17. New targeted treatments for advanced sarcomas.
Li CC; Chen TW
Curr Opin Oncol; 2023 Jul; 35(4):309-314. PubMed ID: 37222206
[TBL] [Abstract] [Full Text] [Related]
18. Next questions in the management of retroperitoneal sarcoma.
Drohan A; Gronchi A
Curr Opin Oncol; 2023 Jul; 35(4):301-308. PubMed ID: 37222202
[TBL] [Abstract] [Full Text] [Related]
19. Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients.
Turinetto M; Meeus P; Ray-Coquard I
Curr Opin Oncol; 2023 Jul; 35(4):288-291. PubMed ID: 37222199
[TBL] [Abstract] [Full Text] [Related]
20. treatment of radiation-associated angiosarcoma.
Dufresne A; Meeus P; Sunyach MP
Curr Opin Oncol; 2023 Jul; 35(4):296-300. PubMed ID: 37222197
[TBL] [Abstract] [Full Text] [Related]
[Next]